Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/1996
05/30/1996WO1996016076A1 Androstane and pregnane series for allosteric modulation of gaba receptor
05/30/1996WO1996016065A1 Heterocyclic compounds and their preparation and use
05/30/1996WO1996016063A1 Morphine and codeine derivatives for use in therapy
05/30/1996WO1996016058A1 Aminomethyl aryl compounds; dopamine receptor subtype selective ligands
05/30/1996WO1996016056A1 Piperazine, piperidine & tetrahydropyridine derivatives useful as 5-ht1 receptor agonists
05/30/1996WO1996016052A2 Certain substituted 1-aryl-3-piperazin-1'-yl propanones
05/30/1996WO1996016040A1 Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
05/30/1996WO1996015812A1 Use of neuregulins as modulators of cellular communication
05/30/1996WO1996015810A1 Monofunctional and/or polyfunctional polylysine conjugates
05/30/1996WO1996015806A1 Human choline acetyltransferase
05/30/1996WO1996015799A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease
05/30/1996WO1996015798A2 Use of bioassimilable boron compounds for the control of subviral pathogenic agents
05/30/1996WO1996015797A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers
05/30/1996WO1996015792A1 Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1'-yl propanones
05/30/1996WO1996015782A1 A method for treating vascular headaches
05/30/1996CA2205969A1 Aminomethyl aryl compounds; dopamine receptor subtype selective ligands
05/30/1996CA2205919A1 Androstane and pregnane series for allosteric modulation of gaba receptor
05/30/1996CA2205661A1 Piperazine, piperidine & tetrahydropyridine derivatives useful as 5-ht1 receptor agonists
05/30/1996CA2205532A1 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
05/30/1996CA2205504A1 Certain substituted 1-aryl-3-piperazin-1'-yl propanones
05/30/1996CA2204850A1 Use of neuregulins as modulators of cellular communication
05/30/1996CA2204147A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
05/29/1996EP0713704A1 2-Amino-1,3-thiazines as nitric oxide synthase inhibitors
05/29/1996EP0713703A2 Substituted phenylpyrimidine derivatives, useful in the treatment or prevention of CNS disorders
05/29/1996EP0713702A1 Anxiolytic agent
05/29/1996EP0713701A1 2-Bromomelatonin in the therapy of sleep disorders
05/29/1996EP0713697A1 Analgesic anti-inflammatory adhesive preparations
05/29/1996EP0713653A1 Fortified fruit juice
05/29/1996EP0713484A1 Inhibitors of biogenic amine transporters
05/29/1996EP0713483A1 Amidine derivatives with nitric oxide synthetase activities
05/29/1996EP0506778B1 Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation
05/29/1996EP0506658B1 Compositions and method for treating painful, inflammatory or allergic disorders
05/29/1996EP0346431B1 Onset-hastened/enhanced analgesia using s(+) ketoprofen
05/29/1996CN1123546A 4-arylisoindole analgesics
05/29/1996CN1123282A Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives
05/29/1996CN1123272A Ysnthetic excitatory amino acids
05/29/1996CN1123142A Fluoxetine pahrmaceutical formulations
05/29/1996CA2163840A1 Potentiation of drug response
05/28/1996US5521315 Olefin substituted long chain compounds
05/28/1996US5521297 Nucleic acids encoding human metabotropic glutamate receptors
05/28/1996US5521220 Treating inflammatory and central nervous system disorders
05/28/1996US5521215 Treatment of nervous system injuries
05/28/1996US5521213 Nonsteroid antiinflammatory agents
05/28/1996US5521209 N-substituted azabicyclo[3.2.0]heptane derivatives as neuroleptics, the preparation and use thereof
05/28/1996US5521197 Analgesics using serotonin antagonist
05/28/1996US5521196 5-HT1F agonists for the treatment of migraine
05/28/1996US5521182 1,2,3,4 tetrahydropteridinone cyclic amide derivatives
05/28/1996US5521178 Combination medication containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence
05/28/1996US5521175 Benzodiazepine derivatives
05/28/1996US5521164 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
05/28/1996US5521156 Cyclic neurokinin A antagonists
05/28/1996US5520931 Controlled release morphine preparation
05/28/1996CA2041330C Percutaneously absorbable eperisone or tolperisone preparation
05/26/1996CA2163724A1 2-amino-1,3-thiazines as inhibitors of nitric oxide synthase
05/24/1996CA2163466A1 Fortified fruit juices
05/23/1996WO1996015244A2 Sensory and motor neuron derived factor (smdf)
05/23/1996WO1996015226A1 Regulation of neural stem cell proliferation
05/23/1996WO1996015224A1 In vitro induction of dopaminergic cells
05/23/1996WO1996015129A1 Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
05/23/1996WO1996015127A1 Pyridazinoquinoline compounds
05/23/1996WO1996015124A1 Hydrate for medicinal use
05/23/1996WO1996015123A1 Pyridine modulators of acetylcholine receptors
05/23/1996WO1996015108A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor agonists
05/23/1996WO1996014877A1 Novel tumor suppressor gene, hic-1
05/23/1996WO1996014861A1 Glial derived neurotrophic factor as a neuroprotective agent
05/23/1996WO1996014846A1 Dihydropyrimidines and uses thereof
05/23/1996WO1996014844A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase
05/23/1996CA2205414A1 Novel tumor suppressor gene, hic-1
05/23/1996CA2205206A1 Hydrate for drug use
05/23/1996CA2204767A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor agonists
05/23/1996CA2204629A1 In vitro induction of dopaminergic cells
05/23/1996CA2204379A1 Sensory and motor neuron derived factor (smdf)
05/23/1996CA2202135A1 Pyridazinoquinoline compounds
05/22/1996EP0713092A1 Method to detect factors in a model of paralysis and method to obtain this model
05/22/1996EP0712837A2 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes
05/22/1996EP0712402A1 Hydroisoquinoline derivatives
05/22/1996EP0712387A1 2-aminoindans as selective dopamine d3 ligands
05/22/1996EP0712311A1 Antiglucocorticoid steroids for the treatment of anxiety disorders
05/22/1996EP0521914B1 A method for regulating neuron development and maintenance
05/21/1996US5519163 Inhibitors of phosphoinositide-specific phospholipase C
05/21/1996US5519131 Synthesis of pyridooxazinyl-indoles
05/21/1996US5519123 Chelating agents, their preparation from the antibiotics salmycin A,B,C, or D, and their use
05/21/1996US5519061 Monoamine oxidase inhibitors, parkinson's disease
05/21/1996US5519039 Pantothenic acid, nicotinic acid and biotin for skins
05/21/1996US5519034 Analgesics
05/21/1996US5519032 Antidepressants, anxiolytics, antiemetics, antipsychotic
05/21/1996US5519025 Anxiolytic and antidepressant agents
05/21/1996US5519023 New aminoalkylchromones, processes for the preparation thereof
05/21/1996US5519007 Lysosphingolipid derivatives
05/21/1996US5518911 Human PAK65
05/17/1996WO1996014435A1 USE OF NEURITE LOCALIZED mRNAs FOR MEDICAL DIAGNOSIS AND THERAPEUTICS
05/17/1996WO1996014401A1 Transgenic organisms and their uses
05/17/1996WO1996014399A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease
05/17/1996WO1996014398A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996WO1996014397A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
05/17/1996WO1996014339A1 Antibodies
05/17/1996WO1996014331A1 Modified neuropeptide y receptors
05/17/1996WO1996014320A1 Substituted tetracyclic azepine derivatives which have affinity for 5-ht2 receptors
05/17/1996WO1996014318A1 SPIRO[HETEROCYCLE-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE]-4'-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
05/17/1996WO1996014316A1 A method of treating urinary bladder dysfunctions
1 ... 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 ... 1833